Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease

The outbreak of SARS-CoV-2 developed into a global pandemic affecting millions of people worldwide. Despite one year of intensive research, the current treatment options for SARS-CoV-2 infected people are still limited. Clearly, novel antiviral compounds for the treatment of SARS-CoV-2 infected pati...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Viruses
Autori principali: van de Sand, Lukas, Bormann, Maren, Alt, Mira, Schipper, Leonie, Heilingloh, Christiane Silke, Steinmann, Eike, Todt, Daniel, Dittmer, Ulf, Elsner, Carina, Witzke, Oliver, Krawczyk, Adalbert
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8066091/
https://ncbi.nlm.nih.gov/pubmed/33918301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13040609
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi